The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Open accessAbstract
BACKGROUND: Classification of endometrial carcinomas (ECs) by morphologic features is irreproducible and imperfectly reflects tumor biology. The authors developed the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE), a molecular classification system based on The Cancer Genome Atlas genomic subgroups, and sought to confirm both feasibility and prognostic ability in a new, large cohort of ECs. METHODS: Immunohistochemistry (IHC) for the presence or absence of mismatch repair (MMR) proteins (to identify MMR deficiency [MMR‐D]), sequencing for polymerase‐ɛ ( POLE ) exonuclease domain mutations ( POLE EDMs), and IHC for tumor protein 53 (p53) (wild type vs null/missense mutations; p53 wt and p53 abn, respectively) were performed on 319 new EC samples. Subgroups were characterized and assessed relative to outcomes. The prognostic ability of ProMisE was compared with that of current risk‐stratification systems (European Society of Medical Oncology [ESMO]). RESULTS: ProMisE decision‐tree classification achieved categorization of all cases and identified 4 prognostic subgroups with distinct overall, disease‐specific, and progression‐free survival ( P < .001). Tumors with POLE EDMs had the most favorable prognosis, and those with p53 abn the worst prognosis, and separation of the 2 middle survival curves (p53 wt and MMR‐D) was observed. There were no significant differences in survival between the ESMO low‐risk and intermediate‐risk groups. ProMisE improved the ability to discriminate outcomes compared with ESMO risk stratification. There was substantial overlap (89%) between the p53 abn and high‐risk ESMO subgroups; but, otherwise, there were no predictable associations between molecular and ESMO risk groups. CONCLUSIONS: Molecular classification of ECs can be achieved using clinically applicable methods and provides independent prognostic information beyond established clinicopathologic risk factors available at diagnosis. Consistent, biologically relevant categorization enables stratification for clinical trials and/or targeted therapy, identification of women who are at increased risk of having Lynch syndrome, and may guide clinical management. Cancer 2017;123:802–13. © 2016 American Cancer Society .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Internal validation of predictive models
Steyerberg, E. W., Harrell, F. E., Borsboom, G. J. J. M., Eijkemans, M. J. C., Vergouwe, Y., & Habbema, J. D. F. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00341-9 · Cited by 2,746
Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00130-0 · Cited by 1,514
Canadian Cancer Statistics 2012: (611042012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e611042012-001 · Cited by 1,492
A clinically applicable molecular-based classification for endometrial cancers
Talhouk, A., McConechy, M. K., Leung, S., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.190 · Cited by 971
Self-citationStelloo, E., Nout, R. A., Osse, E. M., Jürgenliemk-Schulz, I. J., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2878 · Cited by 846
Howitt, B. E., Shukla, S. A., Sholl, L. M., Ritterhouse, L. L., Watkins, J. C., Rodig, S., Stover, E., Strickland, K. C., D’Andrea, A. D., Wu, C. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2151 · Cited by 684
Classification of endometrial carcinoma: more than two types
Murali, R., Soslow, R. A., & Weigelt, B. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70591-6 · Cited by 647
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt353 · Cited by 600
Stelloo, E., Bosse, T., Nout, R. A., MacKay, H. J., Church, D. N., Nijman, H. W., Leary, A., Edmondson, R. J., Powell, M. E., Crosbie, E. J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.43 · Cited by 486
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
Gilks, C. B., Oliva, E., & Soslow, R. A. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827f576a · Cited by 401
Self-citationEvolution of Translational Omics: Lessons Learned and the Path Forward
Micheel, C., Nass, S. J., & Omenn, G. S. (2013) · Cited by 365
Talhouk, A., Hoang, L. N., McConechy, M. K., Nakonechny, Q., Leo, J., Cheng, A., Leung, S., Yang, W., Lum, A., Köbel, M., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.090 · Cited by 225
Self-citationHussein, Y. R., Weigelt, B., Levine, D. A., Schoolmeester, J. K., Dao, L. N., Balzer, B. L., Liles, G., Karlan, B., Köbel, M., Lee, C.-H., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.143 · Cited by 220
McConechy, M. K., Talhouk, A., Li-Chang, H. H., Leung, S., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.541 · Cited by 218
Self-citationReproducibility of histological cell type in high-grade endometrial carcinoma
Han, G., Sidhu, D., Duggan, M. A., Arseneau, J., Cesari, M., Clement, P. B., Ewanowich, C. A., Kalloger, S. E., & Köbel, M. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.102 · Cited by 203
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
McConechy, M. K., Talhouk, A., Leung, S., Chiu, D., Yang, W., Senz, J., Reha-Krantz, L. J., Lee, C.-H., Huntsman, D. G., Gilks, C. B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2233 · Cited by 190
Self-citationMeng, B., Hoang, L. N., McIntyre, J. B., Duggan, M. A., Nelson, G. S., Lee, C.-H., & Köbel, M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.05.006 · Cited by 185
Diagnostic Plots to Reveal Functional Form for Covariates in Multiplicative Intensity Models
Grambsch, P. M., Therneau, T. M., & Fleming, T. R. (1995) · Biometrics · doi:10.2307/2533277 · Cited by 163
Alkushi, A., Köbel, M., Kalloger, S. E., & Gilks, C. B. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181cd6552 · Cited by 158
Self-citationJust how accurate are the major risk stratification systems for early-stage endometrial cancer?
Bendifallah, S., Canlorbe, G., Collinet, P., Arsène, E., Huguet, F., Coutant, C., Hudry, D., Graesslin, O., Raimond, É., Touboul, C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.35 · Cited by 140
Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas
Hoang, L. N., McConechy, M. K., Köbel, M., Han, G., Rouzbahman, M., Davidson, B., Irving, J., Ali, R. H., Leung, S., McAlpine, J. N., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828c63ed · Cited by 135
Self-citationPredictive Modeling: A New Paradigm for Managing Endometrial Cancer
Bendifallah, S., Daraï, É., & Ballester, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4924-2 · Cited by 38
Cello, A. D., Rania, E., Zuccalà, V., Venturella, R., Mocciaro, R., Zullo, F., & Morelli, M. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.09.004 · Cited by 21
Menderes, G., Hicks, C., Black, J. D., Schwab, C. L., & Santin, A. D. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1177018 · Cited by 9
Research works printed but not linked: 5
- Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2014, Canadian Cancer Statistics 2014
- EfronB TibshiraniR.Improvements on Cross‐Validation: The 632 + Bootstrap Method 2012. Available at:http://www.tandfonline.com/doi/abs/10.1080/01621459.1997.10474007. Accessed May 22 2016. · DOI · Paper page
- 10.1097/IGC.0b013e31821454f1 · doi:10.1097/igc.0b013e31821454f1
- 10.1097/AOG.0b013e3181b96ec6 · doi:10.1097/aog.0b013e3181b96ec6
- 10.1097/DCR.0000000000000084 · doi:10.1097/dcr.0000000000000084
Cited by
ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma
Concin, N., Matias-Guiu, X., Vergote, I., Cibula, D., Mirza, M. R., Marnitz, S., Ledermann, J., Bosse, T., Chargari, C., Fagotti, A., et al. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-002230 · Cited by 1,989
Crosbie, E. J., Kitson, S. J., McAlpine, J. N., Mukhopadhyay, A., Powell, M. E., & Singh, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00323-3 · Cited by 1,333
Self-citationFIGO staging of endometrial cancer: 2023
Berek, J. S., Matias‐Guiu, X., Creutzberg, C., Fotopoulou, C., Gaffney, D., Kehoe, S., Lindemann, K., Mutch, D., Concin, N., & Endometrial Cancer Staging Subcommittee, F. W. C. C. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14923 · Cited by 1,000
León-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., Nijman, H. W., Singh, N., Pollock, P. M., Bessette, P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00549 · Cited by 855
Kommoss, S., McConechy, M. K., Kommoss, F., Leung, S., Bunz, A., Magrill, J., Britton, H., Kommoss, F., Grevenkamp, F., Karnezis, A., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy058 · Cited by 776
Self-citation
Metadata
- Authors
- Talhouk, A., McConechy, M. K., Leung, S., Yang, W., Lum, A., Senz, J., Boyd, N., Pike, J., Anglesio, M., Kwon, J. S., Karnezis, A. N., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-01-06
- Volume
- 123
- Issue
- 5
- Pages
- 802-813
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2570729870
- Cited by
- 975
- References
- 28
- FWCI
- 54.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.